IgG inhibition of a monoclonal antibody therapy can help with the selected deactivation of serum IgG with EndoS. Peptide glycosylation can be achieved using a two-step process involving EndoA or ...
Changes in glycosylation are often associated with ... intracellular sialic acid levels is untenable by current lectin or antibody methods. In a cellular model system these mutations can be ...
Monoclonal antibodies, or mAbs, are important tools in medicine. These laboratory-made proteins are widely used in treatments ...
It is glycosylated although not exactly similar ... Framework region; mAb: Monoclonal antibody; PEG: Polyethylene glycol; VH: Variable regions of IgG on heavy chain; VL: Variable regions of ...
The anti-TA-MUC1 is the antibody contained in DS-3939 ... MUC1 is a tumor-specific transmembrane glycoprotein with aberrant glycosylation due to changes of the expression patterns of some ...
The anti-TA-MUC1 is the antibody contained in DS-3939 ... TA-MUC1 is a tumour-specific transmembrane glycoprotein with aberrant glycosylation due to changes of the expression patterns of some ...
of the National Institute of Allergy and Infectious Diseases introduced multiple N-linked glycosylation sites to mask non-CD4bs regions of eOD-GT8 60mer to focus the antibody immune response to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback